GP Surgeries in North Central London Launch Mobile Services

iPLATO HealthcarePatients of GP practices in North Central London including Enfield, Barnet, Haringey, Camden and Islington will soon start receiving appointment reminders and health information via text message. Already in use by a large number of practices in the area this service aims to improve patient access to GP services, reduce unnecessary visits to A&E as well as informing patients about important NHS services such as cancer screening and seasonal flu immunisation.

North Central London NHS Cluster has committed to fund participating surgeries across the Boroughs to use iPLATO Patient Care Messaging for the next three years. With 91% of the UK adult population owning a mobile phone (77% in the 65-74 age group) surgeries can reach a significant number of their patients through this service. Text messages are free to receive for the patient. If they have a smartphone such as iPhone, Blackberry or Android patients will also be able to access information about their local health services via their mobile phone.

Dr. Janet High GP at the Park Lodge Medical Centre, one of the current existing practice said, "Mobile phones are used by most of our patients and so text messaging is an effective way to communicate with them. This service has the potential to significantly increase the number of patients attending clinics as well as saving on surgery administration costs."

Patients who choose to respond to text reminders or access the smartphone service will be charged standard operator rates depending on their individual contract. Patients can opt out of the service at any time by contacting their surgery.

To benefit from these services patients are encouraged to hand in their mobile phone number to their practice. If patients have already their mobile phone number recorded with their GP they will receive a text message to let them know that the service is running as part of service launch.

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mobile health since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.

Most Popular Now

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...